A treatment developed by researchers in the Emirates for the treatment of infections of the emerging coronavirus (Covid-19) has received the protection of intellectual property, which paves the way for this treatment to be widely shared to benefit more patients.
A team of doctors and researchers at the Abu Dhabi Stem Cell Center announced last month the discovery of a new, innovative and promising treatment for infections of the emerging corona virus, which appears to help the body to fight the virus and reduce symptoms of the disease. The treatment includes extracting stem cells from the patient's blood and re-entering them into the lungs after activation By inhaling it with a fine spray.
The initial results of the treatment were promising, as it was tested on 73 patients with «Covid-19» who had moderate to severe symptoms, and all patients responded well to the treatment, indicating that it was effective, but researchers confirmed at that time that the results are still preliminary , And that further analysis is needed.
The stem cell center in Abu Dhabi announced yesterday that the results of the analyzes showed that the treatment is effective and safe as an adjunct to the established treatment protocols.
He pointed out that he was able to obtain the rights to protect intellectual property in this treatment, which paved the way for sharing the details of the treatment with others to try it through a license once an official approval was obtained from the government of the UAE.
The study measured the occurrence of any side effects, monitored the death rate within 28 days, and the time when the patient could improve and be discharged from the hospital, along with the patient's immune response file, signs of disease severity and coagulation tests were evaluated.
Patients whose hemoglobin levels were less than 10, had any blood infections, or had cancer one day, were excluded, or received any unconventional treatment such as treatment with "recovery plasma," and patients under the age of 18 were excluded.